This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages before signing in

Go to /pro/cpd-dashboard page

This page is worth 0.05 CPD credits. CPD dashboard

Go to /account/subscription-details page

This page is worth 0.05 CPD credits. Upgrade to Pro

Impetigo

Last reviewed dd mmm yyyy. Last edited dd mmm yyyy

Authoring team

Impetigo is a highly contagious, superficial skin infection caused by Staphylococcus aureus, Streptococcus pyogenes, or both.

Infection is usually primary but may also complicate other skin disease, such as scabies or eczema.

Key points (1):

  • localised non-bullous impetigo:
    • hydrogen peroxide 1% cream (other topical antiseptics are available but no evidence for impetigo)
    • if hydrogen peroxide unsuitable or ineffective, short-course topical antibiotic
  • Widespread non-bullous impetigo:
    • short-course topical or oral antibiotic
    • ttake account of person’s preferences, practicalities of administration, previous use of topical antibiotics because antimicrobial resistance can develop rapidly with extended or repeated use, and local antimicrobial resistance data
  • Bullous impetigo, systemically unwell, or high risk of complications:
    • short-course oral antibiotic
    • do not offer combination treatment with a topical and oral antibiotic to treat impetigo
    • *5 days is appropriate for most, can be increased to 7 days based on clinical judgement

Reference:


Create an account to add page annotations

Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.